Full text

Turn on search term navigation

© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Chronic diabetic wounds affect 15–20% of patients and are characterized by impaired healing due to disrupted hemostasis, inflammation, proliferation, and extracellular matrix (ECM) remodeling. Low-level light therapy (LLLT) has emerged as a promising noninvasive strategy for enhancing tissue regeneration. Here, we developed a multispectral pulsed LED system combining red and near-infrared light to stimulate wound healing. In vitro photostimulation of human keratinocytes and fibroblasts on biomimetic hydrogels enhanced adhesion, spreading, migration, and proliferation via increased focal adhesion kinase (pFAK), paxillin, and F-actin expression. In vivo, daily LED treatment of streptozotocin-induced diabetic wounds accelerated closure and improved ECM remodeling. Histological and molecular analyses revealed elevated levels of MMPs, interleukins, collagen, fibronectin, FGF2, and TGF-β1, supporting regenerative healing without excessive fibrosis. These findings demonstrate that multispectral pulsed photobiomodulation enhances diabetic wound healing through focal adhesion-mediated cell migration and ECM remodeling, offering a cost-effective and clinically translatable approach for chronic wound therapy.

Details

Title
Multispectral Pulsed Photobiomodulation Enhances Diabetic Wound Healing via Focal Adhesion-Mediated Cell Migration and Extracellular Matrix Remodeling
Author
Choi Jihye 1   VIAFID ORCID Logo  ; Ban Myung Jin 2   VIAFID ORCID Logo  ; Gil Chan Hee 2 ; Hur, Sung Sik 3 ; Danis, Anggradita Laurensia 1 ; Min-Kyu, Kim 3 ; Son, Ji Won 3   VIAFID ORCID Logo  ; Kim Jung Eun 4   VIAFID ORCID Logo  ; Hwang Yongsung 1   VIAFID ORCID Logo 

 Soonchunhyang Institute of Medi-Bio Science, Soonchunhyang University, Asan 31538, Republic of Korea; [email protected] (J.C.); [email protected] (S.S.H.); [email protected] (L.D.A.); [email protected] (M.-K.K.); [email protected] (J.W.S.), Department of Integrated Biomedical Science, Soonchunhyang University, Asan 31538, Republic of Korea 
 Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea; [email protected] (M.J.B.); [email protected] (C.H.G.) 
 Soonchunhyang Institute of Medi-Bio Science, Soonchunhyang University, Asan 31538, Republic of Korea; [email protected] (J.C.); [email protected] (S.S.H.); [email protected] (L.D.A.); [email protected] (M.-K.K.); [email protected] (J.W.S.) 
 Department of Dermatology, Soonchunhyang University Cheonan Hospital, Cheonan 31151, Republic of Korea 
First page
6232
Publication year
2025
Publication date
2025
Publisher
MDPI AG
ISSN
16616596
e-ISSN
14220067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3229148328
Copyright
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.